Learn more

UNIV KENTUCKY

Overview
  • Total Patents
    151
  • GoodIP Patent Rank
    207,252
About

UNIV KENTUCKY has a total of 151 patent applications. Its first patent ever was published in 1937. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ACGT PROGENOMICS AG, PASTORAL GREENHOUSE GAS RES LT and WAKITA TAKAJI.

Patent filings per year

Chart showing UNIV KENTUCKYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chappell Joseph 53
#2 Foon Kenneth A 21
#3 Chatterjee Malaya 21
#4 Chatterjee Sunil K 19
#5 Back Kyoungwhan 18
#6 Cornett Catherine A G 14
#7 Yin Shauhui 13
#8 Lusso Marcos 11
#9 Kohler Heinz 10
#10 Yin Shaohui 9

Latest patents

Publication Filing date Title
US2014073504A1 Use of microbial based soil additive to modulate the phenylpropanoid pathway in plants
US2011166208A1 Nucleotide and Amino Acid Sequences for Calmodulin Protein Methyltransferase
US2009247619A1 Cannabinoid-Containing Compositions and Methods for Their Use
WO2008045556A2 Novel synergistic opioid-cannabinoid codrug for pain management
WO2007149392A1 Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
WO2007133800A2 Toll-like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration
WO2007149163A2 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
WO2007133614A2 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
US2008177521A1 Modeling of mPGES-1 three-dimensional structures: applications in drug design and discovery
WO2007076112A2 Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
WO2007079284A2 Lung cancer diagnostic assay
CN101374962A Lung cancer diagnostic assay
US2007060639A1 Compositions and methods for intranasal delivery of tricyclic cannabinoids
US2006236433A1 Nicotiana hybrids and plant varieties for use in production of pharmaceuticals
US2006234971A1 Calpains as targets for inhibition of prion propagation
US2006067935A1 Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration
US2005272716A1 Use of parthenolide derivatives as antileukemic and cytotoxic agents
US7312242B2 Use of parthenolide derivatives as antileukemic and cytotoxic agents
US2004266737A1 Compounds of use in the treatment of epilepsy, seizure, and electroconvulsive disorders
WO03060464A2 A novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein